BridgeMD
New treatment option for Neonatal Respiratory Distress Related Conditions
Official title Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure
ClinicalTrials.gov ID: NCT07274527
What this study is testing
- What it's testing
- Thick meconium in the amniotic fluid occurs in about one out of seven pregnancies and increases the chance that a newborn may have breathing problems after birth. These problems can include the need for oxygen, breathing support, admission to the neonatal intensive care unit (NICU), or, in severe cases, meconium aspiration syndrome or persistent pulmonary hypertension.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Maternal age greater than or equal to 18 years old
- Singleton pregnancy
- Gestational age of greater than or equal to 36 weeks 0 days gestation
- Cephalic presentation
- Cercial dilation between 2-10 centimeters
You likely can't join if
- Major fetal anomaly
- Multiple gestation
- Eunice Kennedy Shrive National Institute of Child Health and Human Developmet (NICHD) Category III fetal heart tracing
- Contraindication to internal monitors
- Prelabor premature ruptuore of membranes before 36 weeks 0 days gestation, - Inability to consent
See the full eligibility criteria
- Maternal age greater than or equal to 18 years old
- Singleton pregnancy
- Gestational age of greater than or equal to 36 weeks 0 days gestation
- Cephalic presentation
- Cercial dilation between 2-10 centimeters
- Meconium
- Major fetal anomaly
- Multiple gestation
- Eunice Kennedy Shrive National Institute of Child Health and Human Developmet (NICHD) Category III fetal heart tracing
- Contraindication to internal monitors
- Prelabor premature ruptuore of membranes before 36 weeks 0 days gestation, - Inability to consent
The study team makes the final eligibility decision.
Where it's taking place
- Milwaukee, Wisconsin, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milwaukee, Wisconsin, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.